I very much agree with Chris. It's a brilliant question, because I think it hits on a key issue in terms of how we maximize what comes out. We run large-scale projects, and each one is $10 million over four years. The principal investigator might be very interested in publishing his best work, but might not necessarily be the person who is going to recognize an opportunity for commercialization.
That's why we need to be more proactive in putting entrepreneurs in there, embedding them in the projects and getting that value-added aspect. That's what we try to do in a much more proactive way.
With regard to the way we're organized, we have six genome centres across the country. Their job is not only to raise money—it's a 50-50 match—but since a lot of them have business development backgrounds, to go into those projects and pull the best things out.